Barclays Raises Energy Transfer Price Target Suggests Stock May Be Undervalued Supreme Court Declines Metas Appeal in Vermont Instagram Lawsuit Seaport Research Highlights Data Center Power Demand as Growth Catalyst for Texas Instruments TXN Micron Stock Surges as UBS Triples Price Target on AI Memory Demand Prolonged Strait of Hormuz Closure Could Drive Crude Oil to New Highs Piper Sandler Warns 13 BSE 500 Stocks Post Consecutive Declines as Sensex Edges Higher MSC Q4 2025 Earnings 011 EPS No Revenue Disclosure Stock Declines FedEx Q1 2026 Earnings Strong EPS Beat Driven by Cost Discipline and Operational Efficiency OLOX Q3 2023 Earnings SmallerThanExpected Loss Surprises Analysts Enerflex Ltd Q1 2026 Earnings Significant EPS Beat Signals Strong Operational Performance CODI Q1 2026 Earnings Stunning EPS Beat Masks Broader Market Concerns CDNA Q1 2026 Earnings Major EPS Beat Signals StrongerThanExpected Profitability Deswell Industries DSWL Edges Higher as Support Holds Firm Pan American Silver PAAS Slips 26 as Silver Prices Weigh Support at 5124 in Focus Chime Financial CHYM Edges Lower as Key Support Level Comes into Focus US Energy Corp USEG Rallies 43 to 099 as Buyers Defend Support Terns Pharmaceuticals TERN Holds Steady Near Support as Biotech Sector Watches for Catalysts Subsea7 Secures Contract for Vr Energis Goliat Gas Export Project CLX Q1 2026 Earnings EPS Surprise Lifts Results Despite Flat Revenue Iron Mountain IRM Holds Steady Near Support as Data Center Demand Bolsters Outlook 3D Systems Q1 2026 Earnings NarrowerThanExpected Loss Amidst Strategic Shifts Gartner Q1 2026 Earnings EPS Surges Past Estimates Driving Positive Market Response PDCC Q4 2025 Earnings EPS Misses Estimates as Stock Declines Over 3 DCTH Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Continued Commercial Progress HRI Q1 2026 Earnings Significant EPS Beat Driven by Operational Improvements PLG Q4 2023 Earnings Improved Loss per Share Amid PreRevenue Stage Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones